AMRS Stock Overview
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America.
Amyris, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$1.74|
|52 Week High||US$6.79|
|52 Week Low||US$1.44|
|1 Month Change||-32.82%|
|3 Month Change||-53.72%|
|1 Year Change||-71.75%|
|3 Year Change||-50.22%|
|5 Year Change||-50.14%|
|Change since IPO||-99.30%|
Recent News & Updates
|AMRS||US Chemicals||US Market|
Return vs Industry: AMRS underperformed the US Chemicals industry which returned -9.2% over the past year.
Return vs Market: AMRS underperformed the US Market which returned -21.2% over the past year.
|AMRS Average Weekly Movement||19.7%|
|Chemicals Industry Average Movement||6.8%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: AMRS is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 20% a week.
Volatility Over Time: AMRS's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names.
Amyris, Inc. Fundamentals Summary
|AMRS fundamental statistics|
Is AMRS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|AMRS income statement (TTM)|
|Cost of Revenue||US$337.01m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-1.05|
|Net Profit Margin||-131.81%|
How did AMRS perform over the long term?See historical performance and comparison